s6y
Company name or ticker
Search
Martin Daniel C.
3
Deciphera Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, September 20, 2018
Period
Sep 18, 2018
Accession number
0000899243-18-024899
Documents
FORM 3 SUBMISSION
3
EX-24 DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header